The Iopamidol Injection, cataloged under National Stock Number 6505-01-657-0664, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Bracco Diagnostics Inc.. Government technical data includes 9 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-657-0664 |
| Primary Part Number | NDC00270-1316-35 |
| Item Name | Iopamidol Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Bracco Diagnostics Inc. |
| Status | ACTIVE |
| Administration | INTRAVASCULAR |
| Primary Container Content Quantity | 100.0 MILLILITERS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Features Provided | STERILE |
| Primary Container Type | BOTTLE |
| Protective Storage Feature | CONTROLLED ROOM TEMPERATURE AND PROTECT FROM DIRECT SUNLIGHT |
| Pharmaceutical Vehicle Type | AQUEOUS |
| Active Medicament Medicinal Strength | 100.0 MILLILITERS IOPAMIDOL ACTIVE INGREDIENT |
| Total Primary Container Quantity | 10 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC00270-1316-35 PRIMARY | Bracco Diagnostics Inc. (USA) |
| 1316-35 PRIMARY | Bracco Diagnostics Inc. (USA) |
| Reference | Meaning |
|---|---|
| 1418922 | 5/1 Secondary reference U.S. Government activity |
| 6505NCM163025 | 5/1 Secondary reference Defense Medical Standardization Board |
NSN 6505-01-657-0664 is a Iopamidol Injection, manufactured by Bracco Diagnostics Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-657-0664 has 2 manufacturer part numbers on file: NDC00270-1316-35 (Bracco Diagnostics Inc.), 1316-35 (Bracco Diagnostics Inc.).
Key specifications for NDC00270-1316-35: Administration: INTRAVASCULAR; Primary Container Content Quantity: 100.0 MILLILITERS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Features Provided: STERILE. 9 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.